Descriptors


Extend search on down-posting(s)
The Sanford guide to antimicrobial therapy 2003-2004 / Jay P. Sanford / Genval [BE] : GlaxoSmithKline (2003)
The Sanford guide to antimicrobial therapy 2003-2004 [printed text] / Jay P. Sanford, Author ; David N. Gilbert, Author ; Robert C. Jr. Moellering, Author ; Merle A. Sande . - 17th ed. . - Genval (rue du Tilleul 13, 1332, BE) : GlaxoSmithKline, 2003.
ISBN : 1-930808-14-3
Languages : English (eng)
Descriptors: Classification
QV 772 - Commercial preparations. Patent medicinesRecord link: http://kce.docressources.info/index.php?lvl=notice_display&id=136 Hold
Place a hold on this itemCopies (1)
Barcode Call number Media type Location Section Status 10273-00161 QV 772/SAN Book KCE Library (10.124) Available The statistical analysis of failure time data / John D. Kalbfleisch / New York ; Hoboken : J. Wiley (2002)
The statistical analysis of failure time data [printed text] / John D. Kalbfleisch, Author ; Ross L. Prentice, Author . - 2nd ed. . - New York ; Hoboken : J. Wiley, 2002 . - XIII, 439 p. ; 24 cm. - (Wiley series in probability and statistics) .
ISBN : 0-471-36357-X : 97,90
Languages : English (eng)
Descriptors: Classification
QA 276 .K215 Mathematical statistics
Indexation
Failure time data analysis ; Regression analysis ; Survival analysis (Biometry)Record link: http://kce.docressources.info/index.php?lvl=notice_display&id=155 Hold
Place a hold on this itemCopies (1)
Barcode Call number Media type Location Section Status 10273-00051 QA276/KAL Book KCE Library (10.124) Available The structure of scientific revolutions / Thomas Samuel Kuhn / Chicago, IL : University of Chicago Press (1996)
The structure of scientific revolutions [printed text] / Thomas Samuel Kuhn, Author . - 3rd ed. . - Chicago, IL : University of Chicago Press, 1996 . - XIV, 212 p. ; 22 cm. - (International encyclopedia of unified science; 2,2) .
ISBN : 978-0-226-45807-6 : 16,78
Languages : English (eng)
Descriptors: Classification
Q 175 Philosophy. Methodology (General works)
Indexation
History ; Philosophy ; ScienceRecord link: http://kce.docressources.info/index.php?lvl=notice_display&id=265 Hold
Place a hold on this itemCopies (1)
Barcode Call number Media type Location Section Status 10273-00075 Q175/KUH Book KCE Library (10.124) Available The use of whole genome sequencing in clinical practice / Germaine Hanquet / Brussels [Belgium] : KCE = Federaal Kenniscentrum voor de Gezondheidszorg = Centre Fédéral d'Expertise des Soins de Santé = Belgian Health Care Knowledge Centre (2018)
![]()
The use of whole genome sequencing in clinical practice : challenges and organisational considerations for Belgium [printed text] / Germaine Hanquet, Author ; Imgard Vinck, Author ; Nancy Thiry, Author . - Brussels (Doorbuilding (10th), Bld Jardin Botanique, 55, 1000, Belgium) : KCE = Federaal Kenniscentrum voor de Gezondheidszorg = Centre Fédéral d'Expertise des Soins de Santé = Belgian Health Care Knowledge Centre, 2018 . - 81 p. : ill., ; A4. - (KCE Reports. Health Services Research (HSR); 300) .
ISSN : D/2018/10.273/25 : 0,00
Study 2016-05
Languages : English (eng)
Descriptors: Indexation
2016-05 ; Belgium ; Genetic Counseling ; Genetic Services ; Genetic Techniques ; Genetic testing ; Genomics ; Health Care Economics and Organizations ; R300
Classification
QU 460 - GenomicsContents note: SCIENTIFIC REPORT 9 -- 1 BACKGROUND AND SCOPE 9 -- 1.1 GENETIC DISEASES 9 -- 1.2 PROGRESSES IN DNA SEQUENCING 9 -- 1.3 RESEARCH QUESTIONS AND METHODOLOGY 10 -- 2 BACKGROUND ON WHOLE GENOME SEQUENCING 12 -- 2.1 ADVANTAGES OF WHOLE GENOME SEQUENCING 12 -- 2.2 DISADVANTAGES OF WHOLE GENOME SEQUENCING 12 -- 2.3 POTENTIAL USE OF WHOLE GENOME SEQUENCING IN CLINICAL PRACTICE 13 -- 2.4 ECONOMIC ASPECTS OF WHOLE GENOME SEQUENCING 14 -- 2.4.1 Costs of Whole Genome Sequencing 14 -- 2.4.2 Pharmaco-economic evaluations of WGS 17 -- 3 PLACE OF WGS IN CLINICAL PRACTICE 18 -- 3.1 IN COUNTRIES IMPLEMENTING WGS (OR WES) IN CLINICAL CARE 18 -- 3.1.1 The Dutch experience 18 -- 3.1.2 The English experience 19 -- 3.2 POTENTIAL USE OF WGS IN BELGIUM 20 -- 3.2.1 Possible indications for WGS in Belgium 20 -- 4 ORGANISATION OF GENETIC TESTING IN BELGIUM 21 -- 4.1 CENTRES FOR HUMAN GENETICS 21 -- 4.2 GENETIC TESTING AND ANALYSIS 22 -- 4.3 GENETIC COUNSELLING 23 -- 4.4 FINANCING AND REIMBURSEMENT 23 -- 4.4.1 Article 33 of the nomenclature and convention article 22 23 -- 4.4.2 Article 33bis and article 33ter of the nomenclature 25 -- 4.4.3 Regions and Communities 25 -- 4.5 GENETIC PROFESSIONS 26 -- 4.5.1 Medical or Clinical Geneticist 26 -- 4.5.2 Clinical Laboratory Geneticist 26 -- 4.5.3 Medical Laboratory Technician 27 -- 4.5.4 Bio-informatician in genetics 27 -- 4.5.5 Genetic counsellors 27 -- 4.6 PROFESSIONAL ORGANISATIONS AND INTERACTIONS WITH OTHER GROUPS 28 -- 5 MAIN CHALLENGES AND LESSONS LEARNED IN WGS IMPLEMENTION 29 -- 5.1 INFRASTRUCTURE MODELS FOR SEQUENCING 29 -- 5.1.1 Centralised or decentralised sequencing? 29 -- 5.1.2 Sequencing outsourced? 30 -- 5.1.3 Should WGS be restricted to genetic centres? 30 -- 5.2 DECISIONS ON MEDICAL INDICATIONS FOR WGS 30 -- 5.3 DATA ANALYSIS AND INTERPRETATION OF WGS RESULTS 31 -- 5.3.1 Genetic bioinformatics 31 -- 5.3.2 Medical interpretation and reporting 32 -- 5.3.3 Variant of uncertain significance 32 -- 5.3.4 Data storage, protection and sharing 33 -- 5.4 MANAGEMENT OF INCIDENTAL AND SECONDARY FINDINGS 34 -- 5.5 GENETIC COUNSELLING 35 -- 5.6 WGS QUALITY 35 -- 5.7 HUMAN RESOURCES 36 -- 5.7.1 Clinical geneticist 36 -- 5.7.2 Clinical laboratory geneticist (CLG) 36 -- 5.7.3 Bio-informaticians in genetics 37 -- 5.7.4 Genetic counsellors 37 -- 5.8 COST AND FINANCING 37 -- 5.9 THE ORGANISATION OF MEDICAL GENETICS IN BELGIUM 39 -- 6 ORGANISATIONAL PROPOSALS TO ADRESS THESE CHALLENGES 40 -- 6.1 ORGANISATION OF WGS IN THE SHORT TERM 40 -- 6.2 INFRASTRUCTURE FOR WGS 40 -- 6.2.1 Options for sequencing infrastructure 40 -- 6.2.2 Should WGS be restricted to CHG? 41 -- 6.2.3 Centralisation and harmonisation 42 -- 6.3 BIO-INFORMATICS AND MEDICAL INTERPRETATION 44 -- 6.4 DATA STORAGE 44 -- 6.5 A COMMON DATABASE OF VARIANTS 44 -- 6.6 WGS INDICATIONS AND PRESCRIPTION 45 -- 6.7 INCIDENTAL FINDINGS AND GENETIC COUNSELLING 45 -- 6.8 FINANCING OPTIONS 45 -- 6.9 PLAN FOR HUMAN RESOURCES 48 -- 6.10 ORGANISATION OF GENETICS IN BELGIUM 49 Link for e-copy: https://kce.fgov.be/sites/default/files/atoms/files/KCE_300_Whole_genome_Sequenc [...] Format of e-copy: PDF (990 Kb) Record link: http://kce.docressources.info/index.php?lvl=notice_display&id=4369 The use of whole genome sequencing in clinical practice / Mahsa Shabani / Brussels [Belgium] : KCE = Federaal Kenniscentrum voor de Gezondheidszorg = Centre Fédéral d'Expertise des Soins de Santé = Belgian Health Care Knowledge Centre (2018)
![]()
The use of whole genome sequencing in clinical practice : challenges and organisational considerations for Belgium - Legal issues - Supplement [printed text] / Mahsa Shabani, Author ; Danya Vears, Author ; Pascal Borry, Author ; Imgard Vinck, Author . - Brussels (Doorbuilding (10th), Bld Jardin Botanique, 55, 1000, Belgium) : KCE = Federaal Kenniscentrum voor de Gezondheidszorg = Centre Fédéral d'Expertise des Soins de Santé = Belgian Health Care Knowledge Centre, 2018 . - 27 p. : ill., ; A4. - (KCE Reports. Health Services Research (HSR); 300S) .
ISSN : D/2018/10.273/26 : 0,00
Study 2016-05
Languages : English (eng)
Descriptors: Indexation
2016-05 ; Belgium ; Genetic Counseling ; Genetic Services ; Genetic Techniques ; Genetic testing ; Genomics ; Health Care Economics and Organizations ; R300
Classification
QU 460 - GenomicsContents note: SUPPLEMENT 1 -- 1. INTRODUCTION 2 -- 2. WHOLE GENOME SEQUENCING AND UNSOLICITED FINDINGS 2 -- 2.1. TERMINOLOGY 2 -- 2.2. WHAT ARE THE OBLIGATIONS OF THE LABORATORY TO SEARCH FOR FINDINGS THAT ARE UNRELATED TO THE CLINICAL QUESTION? 3 -- 2.3. WHAT ARE THE OBLIGATIONS OF THE LABORATORY TO RETURN CLINICALLY USEFUL FINDINGS THAT ARE UNRELATED TO THE CLINICAL QUESTION? 4 -- 2.4. WHAT ARE THE RIGHTS OF THE PATIENT NOT TO KNOW FINDINGS THAT ARE CLINICALLY IMPORTANT, BUT THAT ARE UNRELATED TO THE CLINICAL QUESTION? 5 -- 3. DATA STORAGE AND SHARING 7 -- 3.1. DIFFERENT TYPES OF DATA 7 -- 3.2. WHAT ARE THE STORAGE OBLIGATIONS FOR RAW DATA AND VARIANT INFORMATION? 8 -- 3.3. LEGAL IMPLICATIONS FOR STORAGE/SEQUENCING BY THIRD PARTY? (I.E. NOT HEALTH CARE SERVICE) 10 -- 3.4. DATA SHARING: DATA EXCHANGE BETWEEN GENETIC CENTRES (AT LEAST VARIANTS, POSSIBLY RAW DATA) 14 -- 4. RESPONSIBILITIES AND LIABILITY 16 -- 5. WHOLE GENOME SEQUENCING AND DIRECT-TO-CONSUMER GENETIC TESTING 17 -- REFERENCES 20 Link for e-copy: https://kce.fgov.be/sites/default/files/atoms/files/KCE_300S_Whole_genome_Sequen [...] Format of e-copy: PDF (490 Kb) Record link: http://kce.docressources.info/index.php?lvl=notice_display&id=4370 Thérapies de soutien en cas de cancer / Kirsten Holdt Henningsen / Brussels [Belgium] : KCE = Federaal Kenniscentrum voor de Gezondheidszorg = Centre Fédéral d'Expertise des Soins de Santé = Belgian Health Care Knowledge Centre (2012)
PermalinkThérapies de soutien en cas de cancer Partie 2 / Leen Verleye / Brussels [Belgium] : KCE = Federaal Kenniscentrum voor de Gezondheidszorg = Centre Fédéral d'Expertise des Soins de Santé = Belgian Health Care Knowledge Centre (2012)
PermalinkThérapies de soutien en cas de cancer - partie 3 / Marijke Eyssen / Brussels [Belgium] : KCE = Federaal Kenniscentrum voor de Gezondheidszorg = Centre Fédéral d'Expertise des Soins de Santé = Belgian Health Care Knowledge Centre (2013)
PermalinkPermalinkPermalinkTNM Classification of malignant tumours / James Brierley ; M. K. Gospodarowicz ; Ch Wittekind / Oxford : Wiley-Blackwell (2016)
PermalinkToekomstscenarios voor de ontwikkeling en prijszetting van geneesmiddelen / Philippe Vandenbroeck / Brussels [Belgium] : KCE = Federaal Kenniscentrum voor de Gezondheidszorg = Centre Fédéral d'Expertise des Soins de Santé = Belgian Health Care Knowledge Centre (2016)
PermalinkTotale Genoomsequencing / Germaine Hanquet / Brussels [Belgium] : KCE = Federaal Kenniscentrum voor de Gezondheidszorg = Centre Fédéral d'Expertise des Soins de Santé = Belgian Health Care Knowledge Centre (2018)
PermalinkTowards a better managed off-label use of drugs / Céline Vannieuwenhuysen / Brussels [Belgium] : KCE = Federaal Kenniscentrum voor de Gezondheidszorg = Centre Fédéral d'Expertise des Soins de Santé = Belgian Health Care Knowledge Centre (2015)
PermalinkPermalink
